The diagnosis and staging of bladder cancer: From RBCs to TURs

Urology

Volumn 67, Issue 3 SUPPL. 1, 2006, Pages 3-8

  Carmack, Adrienne J K ^a   Soloway, Mark S ^a,b,c,d   Grossman, H Barton ^b   Blute, Michael L ^b   Reuter, Victor E ^b   Dinney, Colin P N ^b   Jones, J Stephen ^b   Liou, Louis S ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b Abbott Laboratories ^*

^c ABBOTT LABORATORIES   (United States)

^d FUJIREBIO INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR MATRIX PROTEIN 22; TUMOR ANTIGEN;

BLADDER CANCER; CANCER SCREENING; CANCER STAGING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; ERYTHROCYTE; FLUORESCENCE; HEMATURIA; HUMAN; IMAGING; POLLAKISURIA; PRIORITY JOURNAL; REVIEW; TRANSURETHRAL RESECTION; URINALYSIS; URINARY URGENCY; URINE CYTOLOGY;

EID: 33644769213     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2006.01.026     Document Type: Article

References (41)

1. L.W. Lee , E. Davis Jr Gross urinary hemorrhage a symptom, not a disease JAMA 153 1953 782 784
2. R.F. Sanchez-Ortiz , W.C. Huang , R. Mick An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma J Urol 169 2003 110 115 discussion 115
3. S.S. Chang , J.M. Hassan , M.S. Cookson Delaying radical cystectomy for muscle invasive bladder cancer results in worse pathological stage J Urol 170 2003 1085 1087
4. M. May , T. Nitzke , C. Helke Significance of the time period between diagnosis of muscle invasion and radical cystectomy with regard to the prognosis of transitional cell carcinoma of the urothelium in the bladder Scand J Urol Nephrol 38 2004 231 235
5. H.W. Herr , P.C. Sogani Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166 2001 1296 1299
6. Z. Kirkali , T. Chan , M. Manoharan Bladder cancer: epidemiology, staging and grading, and diagnosis: 2004 Société Internationale d'Urologie (SIU)/World Health Organization (WHO) Bladder Cancer Consensus Panel Consensus Conference Urology 66 suppl 6 2005 4 34
7. R.A. Hiatt , J.D. Ordonez Dipstick urinalysis screening, asymptomatic microhematuria, and subsequent urologic cancers in a population-based sample Cancer Epidemiol Biomarkers Prev 3 1994 439 449
8. J.P. Britton , A.C. Dowell , P. Whelan A community study of bladder cancer screening by the detection of occult urinary bleeding J Urol 148 1992 788 790
9. P. Whelan , J.P. Britton , A.C. Dowell Three-year follow-up of bladder tumors found on screening Br J Urol 72 1993 893 896
10. M.P. Mayfield , P. Whelan Bladder tumours detected on screening results at 7 years Br J Urol 82 1998 825 828
11. E.M. Messing , T.B. Young , V.B. Hunt Comparison of bladder cancer outcome in men undergoing hematuria home screening versus those with standard clinical presentations Urology 45 1995 387 396
12. M.J. Varkarakis , J. Gaeta , R.H. Moore Superficial bladder tumor aspects of clinical progression Urology 4 1974 414 420
13. S.R. Sultana , C.M. Goodman , D.J. Byrne Microscopic haematuria urological investigation using a standard protocol Br J Urol 78 1996 691 698
14. M.H. Khadra , R.S. Pickard , M. Charlton A prospective analysis of 1,930 patients with hematuria to evaluate current diagnostic practice J Urol 163 2000 524 527
15. A.L. Golin , R.S. Howard Asymptomatic microscopic hematuria J Urol 124 1980 389 391
16. D.N. Mohr , K.P. Offord , R.A. Owen Asymptomatic microhematuria and urologic disease a population-based study JAMA 256 1986 224 229
17. G.D. Grossfeld , J.S. Wolf Jr , M.S. Litwan Asymptomatic microscopic hematuria in adults summary of the AUA best practice policy recommendations Am Fam Physician 63 2001 1145 1154
18. H. Zincke , D.C. Utz , G.M. Farrow Review of Mayo Clinic experience with carcinoma in situ Urology 26 1985 39 46
19. W.D. Tissot , A.C. Diokno , K.M. Peters A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis J Urol 172 2004 478 480
20. M.J. Young , M.S. Soloway Office evaluation and management of bladder neoplasms Urol Clin North Am 25 1998 603 611
21. M.S. Soloway Flexible cystourethroscopy alternative to rigid instruments for evaluation of lower urinary tract Urology 25 1985 472 474
22. M.S. Soloway , M. Sofer , A. Vaidya Contemporary management of stage T1 transitional cell carcinoma of the bladder J Urol 167 2002 1573 1583
23. B. Planz , E. Jochims , T. Deix The role of urinary cytology for detection of bladder cancer Eur J Surg Oncol 31 2005 304 308
24. I. Mansoor Analysis of urine cytology at a community hospital J Ayub Med Coll Abbottabad 15 2003 20 23
25. J.A. Witjes Bladder carcinoma in situ in 2003 state of the art Eur Urol 45 2004 142 146
26. G. Nabi , D. Greene , M.O. O'Donnell Suspicious urinary cytology with negative evaluation for malignancy in the diagnostic investigation of haematuria how to follow up? Clin Pathol 57 2004 365 368
27. W.M. Murphy , W.N. Crabtree , A.F. Jukkola The diagnostic value of urine versus bladder washing in patients with bladder cancer J Urol 126 1981 320 322
28. G.L. Schroeder , M.F. Lorenzo-Gomez , S.H. Hautmann A side by side comparison of cytology and biomarkers for bladder cancer detection J Urol 172 2004 1123 1126
29. H.B. Grossman , E.M. Messing , M.S. Soloway Detection of bladder cancer using a point-of-care proteomic assay JAMA 293 2005 810 816
30. B.R. Kipp , R.J. Karnes , S.M. Brankley Monitoring intravesical therapy for superficial bladder cancer using fluorescence in situ hybridization J Urol 173 2005 401 404
31. M.F. Sarosdy , P. Schellhammer , G. Bokinsky Clinical evaluation of multi-target fluorescent in situ hybridization assay for the detection of bladder cancer J Urol 168 2002 1950 1954
32. M.S. Soloway , J. Patel Surgical techniques for endoscopic resection of bladder cancer Urol Clin North Am 19 1992 467 471
33. M.S. Soloway Optical dilator to obviate blind urethral dilatation prior to endoscopic resections Urology 31 1988 427 428
34. J. Schmidbauer , F. Witjes , N. Schmeller Improved detection of urothelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy J Urol 171 2004 135 138
35. W. Loidl , J. Schmidbauer , M. Susani Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence a new approach for bladder cancer detection and surveillance? Eur Urol 47 2005 323 326
36. F. Herranz-Amo , J.M. Diez-Cordero , F. Verdu-Tartajo Need for intravenous urography in patients with primary transitional carcinoma of the bladder? Eur Urol 36 1999 221 224
37. C. Goessl , H.H. Knispel , K. Miller Is routine excretory urography necessary at first diagnosis of bladder cancer? J Urol 157 1997 480 481
38. B. Kim , R.C. Semelka , S.M. Ascher Bladder tumor staging comparison of contrast-enhanced CT, T1- and T2-weighted MR imaging, dynamic gadolinium-enhanced imaging, and late gadolinium-enhanced imaging Radiology 193 1994 239 245
39. A. Tekes , I. Kamel , K. Imam Dynamic MRI of bladder cancer evaluation of staging accuracy AJR Am J Roentgenol 184 2005 121 127
40. V. Ficarra , O. Dalpiaz , N. Alrabi Correlation between clinical and pathological staging in a series of radical cystectomies for bladder carcinoma BJU Int 95 2005 786 790
41. M.L. Paik , M.J. Scolieri , S.L. Brown Limitations of computerized tomography in staging invasive bladder cancer before radical cystectomy J Urol 163 2000 1693 1696